You searched for "SLT"
Steroid treatment for pseudophakic cystoid macular oedema
The authors present a retrospective comparison of 45 eyes of 41 patients treated with 2mg intravitreal triamcinolone (IVT group) and 50 eyes of 42 patients treated with 40mg sub-Tenons triamcinolone (STT group) for pseudophakic cystoid macular oedema (CMO). The visual...BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.
Somatostatin protects retinal pericytes
Diabetic retinopathy (DR) is a complication of diabetes, caused by high blood sugar levels damaging the retinal microvasculature. Mechanisms, such as oxidative stress and deposition of advanced glycation end products, leads to glial cell activation and neuronal apoptosis. Pericytes, contractile...Evolving towards an interventional glaucoma mindset
Traditionally, a newly diagnosed glaucoma patient would be treated first with medical therapy. As the disease progressed or the initial intervention failed to adequately control intraocular pressure (IOP), clinicians would add more drops, selective laser trabeculoplasty (SLT), repeated SLT and...Dr Paul Singh and Prof Gus Gazzard on laser as first line therapy
Both the American Academy of Ophthalmology (AAO) and the European Glaucoma Society (EGS) have updated their preferred practice regimens to recognize or recommend SLT as an initial intervention for glaucoma and the NICE UK are now guiding doctors to use SLT before drops.CALL TO ACTION: Ophthalmology on Myanmar / Thailand border: do you have any redundant kit?
In 1990, the late Doctor Frank Green, a consultant ophthalmologist in Aberdeen, along with Doctor Phillip Ambler, a GP with ophthalmic training, responded to an invitation to provide ophthalmic care for Karen refugees on the northern and eastern Myanmar borders....BELKIN VISION: Increase Efficiency and Reduce Waiting Lists: DSLT in the Real-World Webinar
Join Prof Gus Gazzard, Mr Sheraz Daya and Mr Neil Nathwani as they discuss DSLT in the Real-World and how it can increase efficiency and reduce waiting lists. 08:00PM London
Treatment outcomes for retinal detachment
This is a retrospective, nationwide, multicentre study with retinal detachment (RD) in the Japan-RD registry between 2016 to 2017. The primary outcome was the estimated mean difference of postoperative corrected visual acuity (CVA) in six months and a propensity score...
